Global mRNA Flu Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
An mRNA flu vaccine is a type of vaccine that utilizes messenger RNA (mRNA) technology to stimulate an immune response against the influenza virus. This innovative approach involves introducing synthetic mRNA molecules into the body, which then instruct cells to produce a specific viral protein, typically a harmless piece of the virus's surface. The immune system recognizes this protein as foreign and mounts an immune response, creating memory cells that can quickly respond to future infections by the same virus. mRNA vaccines are designed to be highly specific, rapidly deployable, and capable of eliciting a strong immune response without using live virus components, thus reducing the risk of adverse effects associated with live-attenuated vaccines. They represent a significant advancement in vaccine technology, offering a potentially safer and more effective means of disease prevention.
In 2024, the global mRNA Flu Vaccine market is projected to reach approximately USD xx Million, with expectations to grow at a compound annual growth rate (CAGR) of around xx between 2024 and 2033.
This report provides a deep insight into the global mRNA Flu Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Flu Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Flu Vaccine market in any manner.
Global mRNA Flu Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
BioNTech
CureVac
Novavax
Sanofi
Inovio Pharmaceuticals
Arcturus Therapeutics Holdings
eTheRNA immunotherapies
Valneva
Vaxart
Entos Pharmaceuticals
Abnova Corporation
Anima Biotech
Sarepta Therapeutics
iBio
Barinthus Biotherapeutics
Alnylam Pharmaceuticals
Beam Therapeutics
Market Segmentation (by Type)
mRNA-1010
mRNA-1020
mRNA-1030
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Flu Vaccine Market
Overview of the regional outlook of the mRNA Flu Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Flu Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
An mRNA flu vaccine is a type of vaccine that utilizes messenger RNA (mRNA) technology to stimulate an immune response against the influenza virus. This innovative approach involves introducing synthetic mRNA molecules into the body, which then instruct cells to produce a specific viral protein, typically a harmless piece of the virus's surface. The immune system recognizes this protein as foreign and mounts an immune response, creating memory cells that can quickly respond to future infections by the same virus. mRNA vaccines are designed to be highly specific, rapidly deployable, and capable of eliciting a strong immune response without using live virus components, thus reducing the risk of adverse effects associated with live-attenuated vaccines. They represent a significant advancement in vaccine technology, offering a potentially safer and more effective means of disease prevention.
In 2024, the global mRNA Flu Vaccine market is projected to reach approximately USD xx Million, with expectations to grow at a compound annual growth rate (CAGR) of around xx between 2024 and 2033.
This report provides a deep insight into the global mRNA Flu Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Flu Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Flu Vaccine market in any manner.
Global mRNA Flu Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
BioNTech
CureVac
Novavax
Sanofi
Inovio Pharmaceuticals
Arcturus Therapeutics Holdings
eTheRNA immunotherapies
Valneva
Vaxart
Entos Pharmaceuticals
Abnova Corporation
Anima Biotech
Sarepta Therapeutics
iBio
Barinthus Biotherapeutics
Alnylam Pharmaceuticals
Beam Therapeutics
Market Segmentation (by Type)
mRNA-1010
mRNA-1020
mRNA-1030
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Flu Vaccine Market
Overview of the regional outlook of the mRNA Flu Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Flu Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA Flu Vaccine
1.2 Key Market Segments
1.2.1 mRNA Flu Vaccine Segment by Type
1.2.2 mRNA Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA FLU VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Flu Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global mRNA Flu Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA FLU VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Flu Vaccine Product Life Cycle
3.3 Global mRNA Flu Vaccine Sales by Manufacturers (2020-2025)
3.4 Global mRNA Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Flu Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Flu Vaccine Market Competitive Situation and Trends
3.8.1 mRNA Flu Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Flu Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA FLU VACCINE INDUSTRY CHAIN ANALYSIS
4.1 mRNA Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA FLU VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Flu Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Flu Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MRNA FLU VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Flu Vaccine Sales Market Share by Type (2020-2025)
6.3 Global mRNA Flu Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global mRNA Flu Vaccine Price by Type (2020-2025)
7 MRNA FLU VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Flu Vaccine Market Sales by Application (2020-2025)
7.3 Global mRNA Flu Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Flu Vaccine Sales Growth Rate by Application (2020-2025)
8 MRNA FLU VACCINE MARKET SALES BY REGION
8.1 Global mRNA Flu Vaccine Sales by Region
8.1.1 Global mRNA Flu Vaccine Sales by Region
8.1.2 Global mRNA Flu Vaccine Sales Market Share by Region
8.2 Global mRNA Flu Vaccine Market Size by Region
8.2.1 Global mRNA Flu Vaccine Market Size by Region
8.2.2 Global mRNA Flu Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America mRNA Flu Vaccine Sales by Country
8.3.2 North America mRNA Flu Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Flu Vaccine Sales by Country
8.4.2 Europe mRNA Flu Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Flu Vaccine Sales by Region
8.5.2 Asia Pacific mRNA Flu Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Flu Vaccine Sales by Country
8.6.2 South America mRNA Flu Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Flu Vaccine Sales by Region
8.7.2 Middle East and Africa mRNA Flu Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA FLU VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Flu Vaccine by Region(2020-2025)
9.2 Global mRNA Flu Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Flu Vaccine Production
9.4.1 North America mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.4.2 North America mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Flu Vaccine Production
9.5.1 Europe mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Flu Vaccine Production (2020-2025)
9.6.1 Japan mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Flu Vaccine Production (2020-2025)
9.7.1 China mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.7.2 China mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna Basic Information
10.1.2 Moderna mRNA Flu Vaccine Product Overview
10.1.3 Moderna mRNA Flu Vaccine Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech
10.2.1 BioNTech Basic Information
10.2.2 BioNTech mRNA Flu Vaccine Product Overview
10.2.3 BioNTech mRNA Flu Vaccine Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 CureVac
10.3.1 CureVac Basic Information
10.3.2 CureVac mRNA Flu Vaccine Product Overview
10.3.3 CureVac mRNA Flu Vaccine Product Market Performance
10.3.4 CureVac Business Overview
10.3.5 CureVac SWOT Analysis
10.3.6 CureVac Recent Developments
10.4 Novavax
10.4.1 Novavax Basic Information
10.4.2 Novavax mRNA Flu Vaccine Product Overview
10.4.3 Novavax mRNA Flu Vaccine Product Market Performance
10.4.4 Novavax Business Overview
10.4.5 Novavax Recent Developments
10.5 Sanofi
10.5.1 Sanofi Basic Information
10.5.2 Sanofi mRNA Flu Vaccine Product Overview
10.5.3 Sanofi mRNA Flu Vaccine Product Market Performance
10.5.4 Sanofi Business Overview
10.5.5 Sanofi Recent Developments
10.6 Inovio Pharmaceuticals
10.6.1 Inovio Pharmaceuticals Basic Information
10.6.2 Inovio Pharmaceuticals mRNA Flu Vaccine Product Overview
10.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Product Market Performance
10.6.4 Inovio Pharmaceuticals Business Overview
10.6.5 Inovio Pharmaceuticals Recent Developments
10.7 Arcturus Therapeutics Holdings
10.7.1 Arcturus Therapeutics Holdings Basic Information
10.7.2 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Overview
10.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Market Performance
10.7.4 Arcturus Therapeutics Holdings Business Overview
10.7.5 Arcturus Therapeutics Holdings Recent Developments
10.8 eTheRNA immunotherapies
10.8.1 eTheRNA immunotherapies Basic Information
10.8.2 eTheRNA immunotherapies mRNA Flu Vaccine Product Overview
10.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Product Market Performance
10.8.4 eTheRNA immunotherapies Business Overview
10.8.5 eTheRNA immunotherapies Recent Developments
10.9 Valneva
10.9.1 Valneva Basic Information
10.9.2 Valneva mRNA Flu Vaccine Product Overview
10.9.3 Valneva mRNA Flu Vaccine Product Market Performance
10.9.4 Valneva Business Overview
10.9.5 Valneva Recent Developments
10.10 Vaxart
10.10.1 Vaxart Basic Information
10.10.2 Vaxart mRNA Flu Vaccine Product Overview
10.10.3 Vaxart mRNA Flu Vaccine Product Market Performance
10.10.4 Vaxart Business Overview
10.10.5 Vaxart Recent Developments
10.11 Entos Pharmaceuticals
10.11.1 Entos Pharmaceuticals Basic Information
10.11.2 Entos Pharmaceuticals mRNA Flu Vaccine Product Overview
10.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Product Market Performance
10.11.4 Entos Pharmaceuticals Business Overview
10.11.5 Entos Pharmaceuticals Recent Developments
10.12 Abnova Corporation
10.12.1 Abnova Corporation Basic Information
10.12.2 Abnova Corporation mRNA Flu Vaccine Product Overview
10.12.3 Abnova Corporation mRNA Flu Vaccine Product Market Performance
10.12.4 Abnova Corporation Business Overview
10.12.5 Abnova Corporation Recent Developments
10.13 Anima Biotech
10.13.1 Anima Biotech Basic Information
10.13.2 Anima Biotech mRNA Flu Vaccine Product Overview
10.13.3 Anima Biotech mRNA Flu Vaccine Product Market Performance
10.13.4 Anima Biotech Business Overview
10.13.5 Anima Biotech Recent Developments
10.14 Sarepta Therapeutics
10.14.1 Sarepta Therapeutics Basic Information
10.14.2 Sarepta Therapeutics mRNA Flu Vaccine Product Overview
10.14.3 Sarepta Therapeutics mRNA Flu Vaccine Product Market Performance
10.14.4 Sarepta Therapeutics Business Overview
10.14.5 Sarepta Therapeutics Recent Developments
10.15 iBio
10.15.1 iBio Basic Information
10.15.2 iBio mRNA Flu Vaccine Product Overview
10.15.3 iBio mRNA Flu Vaccine Product Market Performance
10.15.4 iBio Business Overview
10.15.5 iBio Recent Developments
10.16 Barinthus Biotherapeutics
10.16.1 Barinthus Biotherapeutics Basic Information
10.16.2 Barinthus Biotherapeutics mRNA Flu Vaccine Product Overview
10.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Product Market Performance
10.16.4 Barinthus Biotherapeutics Business Overview
10.16.5 Barinthus Biotherapeutics Recent Developments
10.17 Alnylam Pharmaceuticals
10.17.1 Alnylam Pharmaceuticals Basic Information
10.17.2 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Overview
10.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Market Performance
10.17.4 Alnylam Pharmaceuticals Business Overview
10.17.5 Alnylam Pharmaceuticals Recent Developments
10.18 Beam Therapeutics
10.18.1 Beam Therapeutics Basic Information
10.18.2 Beam Therapeutics mRNA Flu Vaccine Product Overview
10.18.3 Beam Therapeutics mRNA Flu Vaccine Product Market Performance
10.18.4 Beam Therapeutics Business Overview
10.18.5 Beam Therapeutics Recent Developments
11 MRNA FLU VACCINE MARKET FORECAST BY REGION
11.1 Global mRNA Flu Vaccine Market Size Forecast
11.2 Global mRNA Flu Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Flu Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Flu Vaccine Market Size Forecast by Region
11.2.4 South America mRNA Flu Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Flu Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global mRNA Flu Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of mRNA Flu Vaccine by Type (2026-2033)
12.1.2 Global mRNA Flu Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of mRNA Flu Vaccine by Type (2026-2033)
12.2 Global mRNA Flu Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global mRNA Flu Vaccine Sales (K Units) Forecast by Application
12.2.2 Global mRNA Flu Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of mRNA Flu Vaccine
1.2 Key Market Segments
1.2.1 mRNA Flu Vaccine Segment by Type
1.2.2 mRNA Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA FLU VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Flu Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global mRNA Flu Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA FLU VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Flu Vaccine Product Life Cycle
3.3 Global mRNA Flu Vaccine Sales by Manufacturers (2020-2025)
3.4 Global mRNA Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Flu Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Flu Vaccine Market Competitive Situation and Trends
3.8.1 mRNA Flu Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Flu Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA FLU VACCINE INDUSTRY CHAIN ANALYSIS
4.1 mRNA Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA FLU VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Flu Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Flu Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MRNA FLU VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Flu Vaccine Sales Market Share by Type (2020-2025)
6.3 Global mRNA Flu Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global mRNA Flu Vaccine Price by Type (2020-2025)
7 MRNA FLU VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Flu Vaccine Market Sales by Application (2020-2025)
7.3 Global mRNA Flu Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Flu Vaccine Sales Growth Rate by Application (2020-2025)
8 MRNA FLU VACCINE MARKET SALES BY REGION
8.1 Global mRNA Flu Vaccine Sales by Region
8.1.1 Global mRNA Flu Vaccine Sales by Region
8.1.2 Global mRNA Flu Vaccine Sales Market Share by Region
8.2 Global mRNA Flu Vaccine Market Size by Region
8.2.1 Global mRNA Flu Vaccine Market Size by Region
8.2.2 Global mRNA Flu Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America mRNA Flu Vaccine Sales by Country
8.3.2 North America mRNA Flu Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Flu Vaccine Sales by Country
8.4.2 Europe mRNA Flu Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Flu Vaccine Sales by Region
8.5.2 Asia Pacific mRNA Flu Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Flu Vaccine Sales by Country
8.6.2 South America mRNA Flu Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Flu Vaccine Sales by Region
8.7.2 Middle East and Africa mRNA Flu Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA FLU VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Flu Vaccine by Region(2020-2025)
9.2 Global mRNA Flu Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Flu Vaccine Production
9.4.1 North America mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.4.2 North America mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Flu Vaccine Production
9.5.1 Europe mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Flu Vaccine Production (2020-2025)
9.6.1 Japan mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Flu Vaccine Production (2020-2025)
9.7.1 China mRNA Flu Vaccine Production Growth Rate (2020-2025)
9.7.2 China mRNA Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna Basic Information
10.1.2 Moderna mRNA Flu Vaccine Product Overview
10.1.3 Moderna mRNA Flu Vaccine Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech
10.2.1 BioNTech Basic Information
10.2.2 BioNTech mRNA Flu Vaccine Product Overview
10.2.3 BioNTech mRNA Flu Vaccine Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 CureVac
10.3.1 CureVac Basic Information
10.3.2 CureVac mRNA Flu Vaccine Product Overview
10.3.3 CureVac mRNA Flu Vaccine Product Market Performance
10.3.4 CureVac Business Overview
10.3.5 CureVac SWOT Analysis
10.3.6 CureVac Recent Developments
10.4 Novavax
10.4.1 Novavax Basic Information
10.4.2 Novavax mRNA Flu Vaccine Product Overview
10.4.3 Novavax mRNA Flu Vaccine Product Market Performance
10.4.4 Novavax Business Overview
10.4.5 Novavax Recent Developments
10.5 Sanofi
10.5.1 Sanofi Basic Information
10.5.2 Sanofi mRNA Flu Vaccine Product Overview
10.5.3 Sanofi mRNA Flu Vaccine Product Market Performance
10.5.4 Sanofi Business Overview
10.5.5 Sanofi Recent Developments
10.6 Inovio Pharmaceuticals
10.6.1 Inovio Pharmaceuticals Basic Information
10.6.2 Inovio Pharmaceuticals mRNA Flu Vaccine Product Overview
10.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Product Market Performance
10.6.4 Inovio Pharmaceuticals Business Overview
10.6.5 Inovio Pharmaceuticals Recent Developments
10.7 Arcturus Therapeutics Holdings
10.7.1 Arcturus Therapeutics Holdings Basic Information
10.7.2 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Overview
10.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Market Performance
10.7.4 Arcturus Therapeutics Holdings Business Overview
10.7.5 Arcturus Therapeutics Holdings Recent Developments
10.8 eTheRNA immunotherapies
10.8.1 eTheRNA immunotherapies Basic Information
10.8.2 eTheRNA immunotherapies mRNA Flu Vaccine Product Overview
10.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Product Market Performance
10.8.4 eTheRNA immunotherapies Business Overview
10.8.5 eTheRNA immunotherapies Recent Developments
10.9 Valneva
10.9.1 Valneva Basic Information
10.9.2 Valneva mRNA Flu Vaccine Product Overview
10.9.3 Valneva mRNA Flu Vaccine Product Market Performance
10.9.4 Valneva Business Overview
10.9.5 Valneva Recent Developments
10.10 Vaxart
10.10.1 Vaxart Basic Information
10.10.2 Vaxart mRNA Flu Vaccine Product Overview
10.10.3 Vaxart mRNA Flu Vaccine Product Market Performance
10.10.4 Vaxart Business Overview
10.10.5 Vaxart Recent Developments
10.11 Entos Pharmaceuticals
10.11.1 Entos Pharmaceuticals Basic Information
10.11.2 Entos Pharmaceuticals mRNA Flu Vaccine Product Overview
10.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Product Market Performance
10.11.4 Entos Pharmaceuticals Business Overview
10.11.5 Entos Pharmaceuticals Recent Developments
10.12 Abnova Corporation
10.12.1 Abnova Corporation Basic Information
10.12.2 Abnova Corporation mRNA Flu Vaccine Product Overview
10.12.3 Abnova Corporation mRNA Flu Vaccine Product Market Performance
10.12.4 Abnova Corporation Business Overview
10.12.5 Abnova Corporation Recent Developments
10.13 Anima Biotech
10.13.1 Anima Biotech Basic Information
10.13.2 Anima Biotech mRNA Flu Vaccine Product Overview
10.13.3 Anima Biotech mRNA Flu Vaccine Product Market Performance
10.13.4 Anima Biotech Business Overview
10.13.5 Anima Biotech Recent Developments
10.14 Sarepta Therapeutics
10.14.1 Sarepta Therapeutics Basic Information
10.14.2 Sarepta Therapeutics mRNA Flu Vaccine Product Overview
10.14.3 Sarepta Therapeutics mRNA Flu Vaccine Product Market Performance
10.14.4 Sarepta Therapeutics Business Overview
10.14.5 Sarepta Therapeutics Recent Developments
10.15 iBio
10.15.1 iBio Basic Information
10.15.2 iBio mRNA Flu Vaccine Product Overview
10.15.3 iBio mRNA Flu Vaccine Product Market Performance
10.15.4 iBio Business Overview
10.15.5 iBio Recent Developments
10.16 Barinthus Biotherapeutics
10.16.1 Barinthus Biotherapeutics Basic Information
10.16.2 Barinthus Biotherapeutics mRNA Flu Vaccine Product Overview
10.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Product Market Performance
10.16.4 Barinthus Biotherapeutics Business Overview
10.16.5 Barinthus Biotherapeutics Recent Developments
10.17 Alnylam Pharmaceuticals
10.17.1 Alnylam Pharmaceuticals Basic Information
10.17.2 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Overview
10.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Market Performance
10.17.4 Alnylam Pharmaceuticals Business Overview
10.17.5 Alnylam Pharmaceuticals Recent Developments
10.18 Beam Therapeutics
10.18.1 Beam Therapeutics Basic Information
10.18.2 Beam Therapeutics mRNA Flu Vaccine Product Overview
10.18.3 Beam Therapeutics mRNA Flu Vaccine Product Market Performance
10.18.4 Beam Therapeutics Business Overview
10.18.5 Beam Therapeutics Recent Developments
11 MRNA FLU VACCINE MARKET FORECAST BY REGION
11.1 Global mRNA Flu Vaccine Market Size Forecast
11.2 Global mRNA Flu Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Flu Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Flu Vaccine Market Size Forecast by Region
11.2.4 South America mRNA Flu Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Flu Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global mRNA Flu Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of mRNA Flu Vaccine by Type (2026-2033)
12.1.2 Global mRNA Flu Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of mRNA Flu Vaccine by Type (2026-2033)
12.2 Global mRNA Flu Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global mRNA Flu Vaccine Sales (K Units) Forecast by Application
12.2.2 Global mRNA Flu Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Flu Vaccine Market Size Comparison by Region (M USD)
Table 5. Global mRNA Flu Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global mRNA Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global mRNA Flu Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global mRNA Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Flu Vaccine as of 2024)
Table 10. Global Market mRNA Flu Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global mRNA Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. mRNA Flu Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global mRNA Flu Vaccine Sales by Type (K Units)
Table 26. Global mRNA Flu Vaccine Market Size by Type (M USD)
Table 27. Global mRNA Flu Vaccine Sales (K Units) by Type (2020-2025)
Table 28. Global mRNA Flu Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global mRNA Flu Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global mRNA Flu Vaccine Market Size Share by Type (2020-2025)
Table 31. Global mRNA Flu Vaccine Price (USD/Unit) by Type (2020-2025)
Table 32. Global mRNA Flu Vaccine Sales (K Units) by Application
Table 33. Global mRNA Flu Vaccine Market Size by Application
Table 34. Global mRNA Flu Vaccine Sales by Application (2020-2025) & (K Units)
Table 35. Global mRNA Flu Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global mRNA Flu Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global mRNA Flu Vaccine Market Share by Application (2020-2025)
Table 38. Global mRNA Flu Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global mRNA Flu Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. Global mRNA Flu Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global mRNA Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global mRNA Flu Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America mRNA Flu Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. North America mRNA Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe mRNA Flu Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe mRNA Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific mRNA Flu Vaccine Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific mRNA Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America mRNA Flu Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. South America mRNA Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa mRNA Flu Vaccine Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa mRNA Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global mRNA Flu Vaccine Production (K Units) by Region(2020-2025)
Table 54. Global mRNA Flu Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global mRNA Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Moderna Basic Information
Table 62. Moderna mRNA Flu Vaccine Product Overview
Table 63. Moderna mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Moderna Business Overview
Table 65. Moderna SWOT Analysis
Table 66. Moderna Recent Developments
Table 67. BioNTech Basic Information
Table 68. BioNTech mRNA Flu Vaccine Product Overview
Table 69. BioNTech mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. BioNTech Business Overview
Table 71. BioNTech SWOT Analysis
Table 72. BioNTech Recent Developments
Table 73. CureVac Basic Information
Table 74. CureVac mRNA Flu Vaccine Product Overview
Table 75. CureVac mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. CureVac Business Overview
Table 77. CureVac SWOT Analysis
Table 78. CureVac Recent Developments
Table 79. Novavax Basic Information
Table 80. Novavax mRNA Flu Vaccine Product Overview
Table 81. Novavax mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Novavax Business Overview
Table 83. Novavax Recent Developments
Table 84. Sanofi Basic Information
Table 85. Sanofi mRNA Flu Vaccine Product Overview
Table 86. Sanofi mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Sanofi Business Overview
Table 88. Sanofi Recent Developments
Table 89. Inovio Pharmaceuticals Basic Information
Table 90. Inovio Pharmaceuticals mRNA Flu Vaccine Product Overview
Table 91. Inovio Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Inovio Pharmaceuticals Business Overview
Table 93. Inovio Pharmaceuticals Recent Developments
Table 94. Arcturus Therapeutics Holdings Basic Information
Table 95. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Overview
Table 96. Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Arcturus Therapeutics Holdings Business Overview
Table 98. Arcturus Therapeutics Holdings Recent Developments
Table 99. eTheRNA immunotherapies Basic Information
Table 100. eTheRNA immunotherapies mRNA Flu Vaccine Product Overview
Table 101. eTheRNA immunotherapies mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. eTheRNA immunotherapies Business Overview
Table 103. eTheRNA immunotherapies Recent Developments
Table 104. Valneva Basic Information
Table 105. Valneva mRNA Flu Vaccine Product Overview
Table 106. Valneva mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Valneva Business Overview
Table 108. Valneva Recent Developments
Table 109. Vaxart Basic Information
Table 110. Vaxart mRNA Flu Vaccine Product Overview
Table 111. Vaxart mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Vaxart Business Overview
Table 113. Vaxart Recent Developments
Table 114. Entos Pharmaceuticals Basic Information
Table 115. Entos Pharmaceuticals mRNA Flu Vaccine Product Overview
Table 116. Entos Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Entos Pharmaceuticals Business Overview
Table 118. Entos Pharmaceuticals Recent Developments
Table 119. Abnova Corporation Basic Information
Table 120. Abnova Corporation mRNA Flu Vaccine Product Overview
Table 121. Abnova Corporation mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Abnova Corporation Business Overview
Table 123. Abnova Corporation Recent Developments
Table 124. Anima Biotech Basic Information
Table 125. Anima Biotech mRNA Flu Vaccine Product Overview
Table 126. Anima Biotech mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Anima Biotech Business Overview
Table 128. Anima Biotech Recent Developments
Table 129. Sarepta Therapeutics Basic Information
Table 130. Sarepta Therapeutics mRNA Flu Vaccine Product Overview
Table 131. Sarepta Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Sarepta Therapeutics Business Overview
Table 133. Sarepta Therapeutics Recent Developments
Table 134. iBio Basic Information
Table 135. iBio mRNA Flu Vaccine Product Overview
Table 136. iBio mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. iBio Business Overview
Table 138. iBio Recent Developments
Table 139. Barinthus Biotherapeutics Basic Information
Table 140. Barinthus Biotherapeutics mRNA Flu Vaccine Product Overview
Table 141. Barinthus Biotherapeutics mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Barinthus Biotherapeutics Business Overview
Table 143. Barinthus Biotherapeutics Recent Developments
Table 144. Alnylam Pharmaceuticals Basic Information
Table 145. Alnylam Pharmaceuticals mRNA Flu Vaccine Product Overview
Table 146. Alnylam Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Alnylam Pharmaceuticals Business Overview
Table 148. Alnylam Pharmaceuticals Recent Developments
Table 149. Beam Therapeutics Basic Information
Table 150. Beam Therapeutics mRNA Flu Vaccine Product Overview
Table 151. Beam Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Beam Therapeutics Business Overview
Table 153. Beam Therapeutics Recent Developments
Table 154. Global mRNA Flu Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 155. Global mRNA Flu Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. North America mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 157. North America mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Europe mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 159. Europe mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Asia Pacific mRNA Flu Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 161. Asia Pacific mRNA Flu Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 162. South America mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 163. South America mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 164. Middle East and Africa mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 165. Middle East and Africa mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 166. Global mRNA Flu Vaccine Sales Forecast by Type (2026-2033) & (K Units)
Table 167. Global mRNA Flu Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 168. Global mRNA Flu Vaccine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 169. Global mRNA Flu Vaccine Sales (K Units) Forecast by Application (2026-2033)
Table 170. Global mRNA Flu Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Flu Vaccine Market Size Comparison by Region (M USD)
Table 5. Global mRNA Flu Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global mRNA Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global mRNA Flu Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global mRNA Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Flu Vaccine as of 2024)
Table 10. Global Market mRNA Flu Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global mRNA Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. mRNA Flu Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global mRNA Flu Vaccine Sales by Type (K Units)
Table 26. Global mRNA Flu Vaccine Market Size by Type (M USD)
Table 27. Global mRNA Flu Vaccine Sales (K Units) by Type (2020-2025)
Table 28. Global mRNA Flu Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global mRNA Flu Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global mRNA Flu Vaccine Market Size Share by Type (2020-2025)
Table 31. Global mRNA Flu Vaccine Price (USD/Unit) by Type (2020-2025)
Table 32. Global mRNA Flu Vaccine Sales (K Units) by Application
Table 33. Global mRNA Flu Vaccine Market Size by Application
Table 34. Global mRNA Flu Vaccine Sales by Application (2020-2025) & (K Units)
Table 35. Global mRNA Flu Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global mRNA Flu Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global mRNA Flu Vaccine Market Share by Application (2020-2025)
Table 38. Global mRNA Flu Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global mRNA Flu Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. Global mRNA Flu Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global mRNA Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global mRNA Flu Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America mRNA Flu Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. North America mRNA Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe mRNA Flu Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe mRNA Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific mRNA Flu Vaccine Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific mRNA Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America mRNA Flu Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. South America mRNA Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa mRNA Flu Vaccine Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa mRNA Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global mRNA Flu Vaccine Production (K Units) by Region(2020-2025)
Table 54. Global mRNA Flu Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global mRNA Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China mRNA Flu Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Moderna Basic Information
Table 62. Moderna mRNA Flu Vaccine Product Overview
Table 63. Moderna mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Moderna Business Overview
Table 65. Moderna SWOT Analysis
Table 66. Moderna Recent Developments
Table 67. BioNTech Basic Information
Table 68. BioNTech mRNA Flu Vaccine Product Overview
Table 69. BioNTech mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. BioNTech Business Overview
Table 71. BioNTech SWOT Analysis
Table 72. BioNTech Recent Developments
Table 73. CureVac Basic Information
Table 74. CureVac mRNA Flu Vaccine Product Overview
Table 75. CureVac mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. CureVac Business Overview
Table 77. CureVac SWOT Analysis
Table 78. CureVac Recent Developments
Table 79. Novavax Basic Information
Table 80. Novavax mRNA Flu Vaccine Product Overview
Table 81. Novavax mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Novavax Business Overview
Table 83. Novavax Recent Developments
Table 84. Sanofi Basic Information
Table 85. Sanofi mRNA Flu Vaccine Product Overview
Table 86. Sanofi mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Sanofi Business Overview
Table 88. Sanofi Recent Developments
Table 89. Inovio Pharmaceuticals Basic Information
Table 90. Inovio Pharmaceuticals mRNA Flu Vaccine Product Overview
Table 91. Inovio Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Inovio Pharmaceuticals Business Overview
Table 93. Inovio Pharmaceuticals Recent Developments
Table 94. Arcturus Therapeutics Holdings Basic Information
Table 95. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Overview
Table 96. Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Arcturus Therapeutics Holdings Business Overview
Table 98. Arcturus Therapeutics Holdings Recent Developments
Table 99. eTheRNA immunotherapies Basic Information
Table 100. eTheRNA immunotherapies mRNA Flu Vaccine Product Overview
Table 101. eTheRNA immunotherapies mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. eTheRNA immunotherapies Business Overview
Table 103. eTheRNA immunotherapies Recent Developments
Table 104. Valneva Basic Information
Table 105. Valneva mRNA Flu Vaccine Product Overview
Table 106. Valneva mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Valneva Business Overview
Table 108. Valneva Recent Developments
Table 109. Vaxart Basic Information
Table 110. Vaxart mRNA Flu Vaccine Product Overview
Table 111. Vaxart mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Vaxart Business Overview
Table 113. Vaxart Recent Developments
Table 114. Entos Pharmaceuticals Basic Information
Table 115. Entos Pharmaceuticals mRNA Flu Vaccine Product Overview
Table 116. Entos Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Entos Pharmaceuticals Business Overview
Table 118. Entos Pharmaceuticals Recent Developments
Table 119. Abnova Corporation Basic Information
Table 120. Abnova Corporation mRNA Flu Vaccine Product Overview
Table 121. Abnova Corporation mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Abnova Corporation Business Overview
Table 123. Abnova Corporation Recent Developments
Table 124. Anima Biotech Basic Information
Table 125. Anima Biotech mRNA Flu Vaccine Product Overview
Table 126. Anima Biotech mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Anima Biotech Business Overview
Table 128. Anima Biotech Recent Developments
Table 129. Sarepta Therapeutics Basic Information
Table 130. Sarepta Therapeutics mRNA Flu Vaccine Product Overview
Table 131. Sarepta Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Sarepta Therapeutics Business Overview
Table 133. Sarepta Therapeutics Recent Developments
Table 134. iBio Basic Information
Table 135. iBio mRNA Flu Vaccine Product Overview
Table 136. iBio mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. iBio Business Overview
Table 138. iBio Recent Developments
Table 139. Barinthus Biotherapeutics Basic Information
Table 140. Barinthus Biotherapeutics mRNA Flu Vaccine Product Overview
Table 141. Barinthus Biotherapeutics mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Barinthus Biotherapeutics Business Overview
Table 143. Barinthus Biotherapeutics Recent Developments
Table 144. Alnylam Pharmaceuticals Basic Information
Table 145. Alnylam Pharmaceuticals mRNA Flu Vaccine Product Overview
Table 146. Alnylam Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Alnylam Pharmaceuticals Business Overview
Table 148. Alnylam Pharmaceuticals Recent Developments
Table 149. Beam Therapeutics Basic Information
Table 150. Beam Therapeutics mRNA Flu Vaccine Product Overview
Table 151. Beam Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Beam Therapeutics Business Overview
Table 153. Beam Therapeutics Recent Developments
Table 154. Global mRNA Flu Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 155. Global mRNA Flu Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. North America mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 157. North America mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Europe mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 159. Europe mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Asia Pacific mRNA Flu Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 161. Asia Pacific mRNA Flu Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 162. South America mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 163. South America mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 164. Middle East and Africa mRNA Flu Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 165. Middle East and Africa mRNA Flu Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 166. Global mRNA Flu Vaccine Sales Forecast by Type (2026-2033) & (K Units)
Table 167. Global mRNA Flu Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 168. Global mRNA Flu Vaccine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 169. Global mRNA Flu Vaccine Sales (K Units) Forecast by Application (2026-2033)
Table 170. Global mRNA Flu Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of mRNA Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Flu Vaccine Market Size (M USD), 2024-2033
Figure 5. Global mRNA Flu Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global mRNA Flu Vaccine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Flu Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Flu Vaccine Product Life Cycle
Figure 13. mRNA Flu Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global mRNA Flu Vaccine Revenue Share by Manufacturers in 2024
Figure 15. mRNA Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market mRNA Flu Vaccine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Flu Vaccine Revenue in 2024
Figure 18. Industry Chain Map of mRNA Flu Vaccine
Figure 19. Global mRNA Flu Vaccine Market PEST Analysis
Figure 20. Global mRNA Flu Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Flu Vaccine Market Share by Type
Figure 27. Sales Market Share of mRNA Flu Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Flu Vaccine by Type in 2024
Figure 29. Market Size Share of mRNA Flu Vaccine by Type (2020-2025)
Figure 30. Market Size Share of mRNA Flu Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Flu Vaccine Market Share by Application
Figure 33. Global mRNA Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Flu Vaccine Sales Market Share by Application in 2024
Figure 35. Global mRNA Flu Vaccine Market Share by Application (2020-2025)
Figure 36. Global mRNA Flu Vaccine Market Share by Application in 2024
Figure 37. Global mRNA Flu Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Flu Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Flu Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America mRNA Flu Vaccine Sales Market Share by Country in 2024
Figure 43. North America mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Flu Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Flu Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Flu Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Flu Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Flu Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe mRNA Flu Vaccine Sales Market Share by Country in 2024
Figure 53. Europe mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Flu Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Flu Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific mRNA Flu Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Flu Vaccine Market Size Market Share by Region in 2024
Figure 68. China mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Flu Vaccine Sales and Growth Rate (K Units)
Figure 79. South America mRNA Flu Vaccine Sales Market Share by Country in 2024
Figure 80. South America mRNA Flu Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Flu Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Flu Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa mRNA Flu Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Flu Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Flu Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Flu Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global mRNA Flu Vaccine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global mRNA Flu Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global mRNA Flu Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global mRNA Flu Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global mRNA Flu Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global mRNA Flu Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of mRNA Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Flu Vaccine Market Size (M USD), 2024-2033
Figure 5. Global mRNA Flu Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global mRNA Flu Vaccine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Flu Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Flu Vaccine Product Life Cycle
Figure 13. mRNA Flu Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global mRNA Flu Vaccine Revenue Share by Manufacturers in 2024
Figure 15. mRNA Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market mRNA Flu Vaccine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Flu Vaccine Revenue in 2024
Figure 18. Industry Chain Map of mRNA Flu Vaccine
Figure 19. Global mRNA Flu Vaccine Market PEST Analysis
Figure 20. Global mRNA Flu Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Flu Vaccine Market Share by Type
Figure 27. Sales Market Share of mRNA Flu Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Flu Vaccine by Type in 2024
Figure 29. Market Size Share of mRNA Flu Vaccine by Type (2020-2025)
Figure 30. Market Size Share of mRNA Flu Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Flu Vaccine Market Share by Application
Figure 33. Global mRNA Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Flu Vaccine Sales Market Share by Application in 2024
Figure 35. Global mRNA Flu Vaccine Market Share by Application (2020-2025)
Figure 36. Global mRNA Flu Vaccine Market Share by Application in 2024
Figure 37. Global mRNA Flu Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Flu Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Flu Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America mRNA Flu Vaccine Sales Market Share by Country in 2024
Figure 43. North America mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Flu Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Flu Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Flu Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Flu Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Flu Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe mRNA Flu Vaccine Sales Market Share by Country in 2024
Figure 53. Europe mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Flu Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Flu Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific mRNA Flu Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Flu Vaccine Market Size Market Share by Region in 2024
Figure 68. China mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Flu Vaccine Sales and Growth Rate (K Units)
Figure 79. South America mRNA Flu Vaccine Sales Market Share by Country in 2024
Figure 80. South America mRNA Flu Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Flu Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Flu Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa mRNA Flu Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Flu Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Flu Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Flu Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa mRNA Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Flu Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China mRNA Flu Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global mRNA Flu Vaccine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global mRNA Flu Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global mRNA Flu Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global mRNA Flu Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global mRNA Flu Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global mRNA Flu Vaccine Market Share Forecast by Application (2026-2033)
